Jump to content

Tobacco and other drugs

From Wikipedia, the free encyclopedia

An association between tobacco and other drug use has been well established. The nature of this association remains unclear. The two main theories, which are not mutually exclusive, are the phenotypic causation (gateway) model and the correlated liabilities model. The causation model argues that smoking is a primary influence on future drug use, while the correlated liabilities model argues that smoking and other drug use are predicated on genetic or environmental factors.

Causation model[edit]

A 1994 report from the Center on Addiction and Substance Abuse at Columbia University, found a correlation between the use of cigarettes and alcohol and the subsequent use of cannabis. The report asserted a link between alcohol and cannabis use and the subsequent use of illicit drugs like cocaine.[1] It found that when younger children used, the more often they use them, the more likely they were to use cocaine, heroin, hallucinogens and other illicit drugs. The report concludes that the data is already robust enough to make a strong case to step up efforts to prevent childhood use of cigarettes and to take firm steps to reduce children’s access to these "gateway drugs".[2]

Researchers have found that craving nicotine also increases craving for illicit drugs among drug abusers who smoke tobacco, and this suggests that smokers in drug rehabilitation programs may be less successful than nonsmokers in staying off drugs.[3]

In mice, nicotine increased the probability of later consumption of cocaine. the experiments permitted concrete conclusions on the underlying molecular biological alteration in the brain.[4] The biological changes in mice correspond to the epidemiological observations in humans that nicotine consumption is coupled to an increased probability of later use of cocaine.[5]

Correlative model[edit]

Smoking may have a genetic predisposing factor; one 1990 study posited that 52% of the variance in smoking behaviour is attributable to heritable factors.[6][7] The concept received support from a large-scale genetic analysis of 2016 that showed a genetic basis for the connection of the prevalence of cigarette smoking and cannabis use during the life of a person.[8]

See also[edit]


  1. ^ Cigarettes, Alcohol, Marijuana: Gateways to Illicit Drug Use, Center on Addiction and Substance Abuse at Columbia University, October 1994, retrieved 17 July 2007
  2. ^ Betty Ford Center - Dr. James West Public Q&A Page. URL Accessed October, 2006
  3. ^ The National Institute on Drug Abuse (NIDA) Archived 2005-11-03 at the Wayback Machine, part of the NIH, a component of the U.S. Department of Health and Human Services. - Nicotine Craving and Heavy Smoking May Contribute to Increased Use of Cocaine and Heroin - Patrick Zickler, NIDA NOTES Staff Writer. URL Accessed October, 2006
  4. ^ E. R. Kandel; D. B. Kandel (2014). "A Molecular Basis for Nicotine as a Gateway Drug". New England Journal of Medicine. 371 (10): 932–943. doi:10.1056/NEJMsa1405092. PMC 4353486. PMID 25184865.
  5. ^ Keyes, K. M.; Hamilton, A; Kandel, D. B. (2016). "Birth Cohorts Analysis of Adolescent Cigarette Smoking and Subsequent Marijuana and Cocaine Use". American Journal of Public Health. 106 (6): 1143–9. doi:10.2105/AJPH.2016.303128. PMC 4880234. PMID 27077359.
  6. ^ Swan, G. E.; Carmelli, D; Rosenman, R. H.; Fabsitz, R. R.; Christian, J. C. (1990). "Smoking and alcohol consumption in adult male twins: Genetic heritability and shared environmental influences". Journal of Substance Abuse. 2 (1): 9–50. doi:10.1016/S0899-3289(05)80044-6. PMID 2136102.
  7. ^ Hall, W; Madden, P; Lynskey, M (2002). "The genetics of tobacco use: Methods, findings and policy implications". Tobacco Control. 11 (2): 119–124. doi:10.1136/tc.11.2.119. PMC 1763861. PMID 12035004.
  8. ^ Stringer, S; Minică, C. C.; Verweij, K. J.; Mbarek, H; Bernard, M; Derringer, J; Van Eijk, K. R.; Isen, J. D.; Loukola, A; MacIejewski, D. F.; Mihailov, E; Van Der Most, P. J.; Sánchez-Mora, C; Roos, L; Sherva, R; Walters, R; Ware, J. J.; Abdellaoui, A; Bigdeli, T. B.; Branje, S. J.; Brown, S. A.; Bruinenberg, M; Casas, M; Esko, T; Garcia-Martinez, I; Gordon, S. D.; Harris, J. M.; Hartman, C. A.; Henders, A. K.; et al. (2016). "Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium". Translational Psychiatry. 6 (3): e769. doi:10.1038/tp.2016.36. PMC 4872459. PMID 27023175.